{Reference Type}: Case Reports
{Title}: Aberrant splicing caused by a novel KMT2A variant in Wiedemann-Steiner syndrome.
{Author}: Niu J;Teng X;Zhang J;
{Journal}: Mol Genet Genomic Med
{Volume}: 12
{Issue}: 3
{Year}: 2024 Mar
{Factor}: 2.473
{DOI}: 10.1002/mgg3.2415
{Abstract}: BACKGROUND: Wiedemann-Steiner syndrome (WSS) is a rare autosomal-dominant disorder caused by KMT2A variants. The aim of this study was to characterize a novel KMT2A variant in a child with WSS and demonstrate integrated diagnostic approaches.
METHODS: A 3-year-old female with developmental delay, distinctive facial features, and anal fistula underwent whole exome sequencing (WES). RNA analysis was performed to assess splicing effects caused by a novel variant.
RESULTS: WES identified novel heterozygous KMT2A c.5664+6T>C variant initially classified as a variant of uncertain significance. RNA analysis provided evidence of aberrant splicing (exon 20 skipping), allowing reclassification to likely pathogenic. The patient exhibited typical WSS features along with a potential novel finding of anal fistula.
CONCLUSIONS: This report describes a novel non-canonical splice site variant in KMT2A associated with WSS. RNA analysis was critical for variant reclassification. Detailed phenotypic evaluation revealed common and expanded WSS manifestations. This case highlights the importance of combining clinical assessment, DNA testing, and RNA functional assays for the diagnosis of rare genetic disorders.